|
JN Partners |
[·ÎÄÃCRO] ±Û·Î¹ú PM / ÀçÅð¡´É/ ¿Ü±¹°èÁ¦¾à»ç ±Ù¹«ÀÚ È¯¿µ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
8³â¡è |
ä¿ë½Ã |
02.24 |
|
|
JN Partners |
[·ÎÄÃCRO] ±Û·Î¹ú PM / ÀçÅð¡´É/ ¿Ü±¹°èÁ¦¾à»ç ±Ù¹«ÀÚ È¯¿µ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
8³â¡è |
ä¿ë½Ã |
02.16 |
|
|
Á¦À̾ØÆÄÆ®³ÊÁîÄÚ¸®¾Æ(ÁÖ) |
[»óÀå¾ÕµÐ ¹ÙÀÌ¿À»ç] ÀÓ»ó PM / ½ºÅå¿É¼ÇºÎ¿©
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
8³â¡è |
ä¿ë½Ã |
05.10 |
|
|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
´ëÇüÁ¦¾à»ç ½Å¾à°³¹ßÆÀÀå(°úÂ÷Àå±Þ)
¼¿ï °³²±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
8³â¡è |
ä¿ë½Ã |
11.23 |
|
|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
»óÀåÁ¦¾à»ç ÀÓ»ó°³¹ß(7³âÀÌ»ó)-ASAP
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
08.30 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Sales & Marketing Manager(ÇǺΰú)/±¹³»À¯¸íÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
7³â¡è |
ä¿ë½Ã |
12.27 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Clinical Research Manager/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
06.25 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Head of Clinical Development(Clinical Research)/¿Ü±¹°èÁ¦
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
10.23 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
BD Sr. Specialist/¿Ü±¹°è±Û·Î¹úÁ¦¾à»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
7³â¡è |
ä¿ë½Ã |
03.13 |
|
|
¾Æµ¥ÄÚÄÚ¸®¾Æ |
[ÀÇ·á±â±â ¹× ÀǾàÇ° ÄÁ¼³ÆÃ] RA manager
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
7³â¡è |
ä¿ë½Ã |
07.11 |
|
|
(ÁÖ)ºñºñÆÄÆ®³Ê½º |
[¿Ü±¹°è/ÀÇ·á±â±â] RA
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
7³â¡è |
ä¿ë½Ã |
10.19 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
»ç¾÷°³¹ß½ÇÆÀÀå(Business Development Team Leader)/±¹³»À¯
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¶óÀ̼¾½ºIn/Out |
7³â¡è |
ä¿ë½Ã |
09.19 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
»ç¾÷°³¹ß½ÇÆÀÀå(Business Development Team Leader)/±¹³»À¯
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¶óÀ̼¾½ºIn/Out |
7³â¡è |
ä¿ë½Ã |
09.24 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Clinical Project Leader/±¹³»À¯¸íÁ¦¾àȸ»ç
¼¿ï °³²±¸, ¼¿ï °³²±¸, ¼¿ï °³²±¸ | Çз¹«°ü |
¾à»ç/ÇѾà»ç |
7³â¡è |
ä¿ë½Ã |
09.24 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
»ç¾÷°³¹ß½ÇÆÀÀå(Business Development Team Leader)/±¹³»À¯
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¶óÀ̼¾½ºIn/Out |
7³â¡è |
ä¿ë½Ã |
09.28 |
|